Landscape Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Landscape Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.39M	Sell	14,129 -1,176	-8%	-$203K	0.15%	210
2025 Q4	$2.8M	Sell	15,305 -3,983	-21%	-$556K	0.19%	167
2025 Q3	$2.34M	Buy	19,288 +13,579	+238%	+$1.53M	0.15%	207
2025 Q2	$596K	Buy	5,709 +292	+5%	+$30.9K	0.05%	425
2025 Q1	$632K	Buy	+5,417	New	+$617K	0.06%	377
2024 Q4	–	Sell	-6,513	Closed	-$585K	–	723
2024 Q3	$585K	Buy	+6,513	New	+$569K	0.06%	373

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Landscape Capital Management's AXSM Position: Q1 2026 in Review

Landscape Capital Management reduced its Axsome Therapeutics (AXSM) stake by 7.7% in Q1 2026, selling an estimated $203K and leaving 14,129 shares worth $2.39M. The position accounts for 0.15% of the portfolio, ranked #210.

Landscape Capital Management first reported a position in AXSM in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.8M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Landscape Capital Management held 14,129 shares of Axsome Therapeutics worth $2.39M as of Q1 2026.
Landscape Capital Management sold 1,176 Axsome Therapeutics shares in Q1 2026, an estimated $203K.
Axsome Therapeutics made up 0.15% of Landscape Capital Management's portfolio in Q1 2026, its #210 holding.
Landscape Capital Management first reported a position in Axsome Therapeutics in Q3 2024 and has held it in 6 quarters since.
Landscape Capital Management's Axsome Therapeutics position peaked at $2.8M in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.